BiTEŽ Antibody Platform
How a BiTE Antibody Works
Scientific Publications
Blinatumomab (MT103) and Other BiTE Antibodies
Adecatumumab (MT201)
and EpCAM Target
MT203 & MT204
MT293 (TRC093)
New Antibody Constructs
and Target Discovery
Scientific Conferences
 
About UsPipelineTechnologyPartneringInvestor RelationsCareers
 
   
 
MT293 (TRC093)

Targeting of humanized antibody D93 to sites of angiogenesis and tumor growth by binding to multiple epitopes on denatured collagens
Freimark, B. et. al. Mol Immunol 44: 3741-3750 (2007)

Abstract not available

Novel humanized antibody D93 inhibits angiogenesis and tumor growth by binding to cryptic sites in collagen: an extracellular matrix based approach
Pernasetti, F. et al.  Int J Oncol 29: 1371-1379 (2006)

Abstract
 
   
ContactDirectionsEmail Alert 
HomeImprintLegal Notices